Qiu Xinzhu, He Hongbo, Zeng Hao, Tong Xiaopeng, Liu Qing
Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
Front Oncol. 2021 Oct 21;11:751180. doi: 10.3389/fonc.2021.751180. eCollection 2021.
Soft tissue sarcomas on extremities with regional lymph nodes metastasis (STSE-RLNM) is a devastating situation. Optimizing therapeutic approaches is vital but hampered by a shortage of randomized trials. We used a population-level database to evaluate radiotherapy's impact on sarcoma-specific survival (SSS) and overall survival (OS) for surgery for STSE-RLNM.
We retrospectively screened data from the SEER database (2004-2015), and 265 patients with STSE-RLNM who received surgery, with (134) or without (131) radiotherapy, were enrolled in this study. A propensity-score-matched analysis with the inverse probability of treatment weighting (IPTW) Kaplan-Meier curve was created. The log-rank test and Cox regression analysis were performed to compare SSS and OS in patients with and without radiotherapy. Further analysis of radiotherapy time was conducted, and the Kaplan-Meier curve and the log-rank test were done. Landmark analysis was introduced to attenuate the immortal bias.
In the original unadjusted cohort, the radiotherapy + surgery group is associated with improved SSS [hazard ratio (HR), 0.66; 95% CI, 0.47-0.91; p = 0.011] and OS (HR, 0.64; 95% CI, 0.47-0.88; p = 0.006). This significant treatment effect was also noted in IPTW-adjusted Cox regression either on SSS (HR, 0.65; 95% CI, 0.45-0.93; p = 0.020) or on OS (HR, 0.64; 95% CI, 0.46-0.91; p = 0.013). The Kaplan-Meier curve and log-rank test showed that pre- and postoperative radiotherapy was not related to SSS (p = 0.980 or OS (p = 0.890).
Radiotherapy and surgery has a significant benefit on the prognosis of patients with STSE-RLNM compared to surgery alone. These findings should be considered when making treatment decisions for them.
伴有区域淋巴结转移的四肢软组织肉瘤(STSE-RLNM)是一种严重的情况。优化治疗方法至关重要,但由于缺乏随机试验而受到阻碍。我们使用了一个人群水平的数据库来评估放疗对STSE-RLNM手术患者的肉瘤特异性生存率(SSS)和总生存率(OS)的影响。
我们回顾性筛选了SEER数据库(2004 - 2015年)中的数据,265例接受手术的STSE-RLNM患者被纳入本研究,其中134例接受了放疗,131例未接受放疗。创建了倾向评分匹配分析及采用治疗权重逆概率(IPTW)的Kaplan-Meier曲线。进行对数秩检验和Cox回归分析以比较接受和未接受放疗患者的SSS和OS。对放疗时间进行了进一步分析,并绘制了Kaplan-Meier曲线和进行了对数秩检验。引入了地标分析以减轻不朽偏倚。
在最初未调整的队列中,放疗 + 手术组的SSS有所改善[风险比(HR),0.66;95%置信区间(CI),0.47 - 0.91;p = 0.011],OS也有所改善(HR,0.64;95% CI,0.47 - 0.88;p = 0.006)。在IPTW调整的Cox回归中,无论是SSS(HR,0.65;95% CI,0.45 - 0.93;p = 0.020)还是OS(HR,0.64;95% CI,0.46 - 0.91;p = 0.013),都观察到了这种显著的治疗效果。Kaplan-Meier曲线和对数秩检验表明,术前和术后放疗与SSS(p = 0.980)或OS(p = 0.890)无关。
与单纯手术相比,放疗联合手术对STSE-RLNM患者的预后有显著益处。在为他们做出治疗决策时应考虑这些发现。